Rate of Anti-Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor Seroconversion in Patients with Undifferentiated Arthritis or Early Rheumatoid Arthritis Treated with Abatacept. KU Leuven
Daily practice effectiveness of a step-down treatment in comparison with a tight step-up for early rheumatoid arthritis KU Leuven
Misdiagnosis of Rheumatoid Arthritis in a Long-Term Cohort of Early Arthritis Based on the ACR-1987 Classification Criteria Vrije Universiteit Brussel
Objective: Correct diagnosis of early rheumatoid arthritis (RA) is essential for optimal treatment choices. No pathognomonic test is available, and diagnosis is based on classification criteria, which can result in misdiagnosis. Here, we examined the differences between actual and misdiagnosed RA cases in a long-term cohort of patients included based on the ACR-1987 classification criteria.
Methods: Patients in the BARFOT (Better ...
DO WE NEED A PATIENT PEER MENTOR PROGRAM IN DAILY PRACTICE FOR PATIENTS WITH EARLY RHEUMATOID ARTHRITIS AND IF SO, HOW SHOULD THIS BE ORGANIZED? KU Leuven
A detailed analysis of treatment delay from the onset of symptoms in early rheumatoid arthritis patients Vrije Universiteit Brussel KU Leuven
Objectives: A treatment delay of more than 12 weeks can negatively affect treatment response in rheumatoid arthritis (RA). Our aim was to quantify the different stages of delay before RA treatment in different rheumatology centres and to explore influencing factors. Method: A total of 156 disease-modifying anti-rheumatic drug (DMARD)-naive early RA patients were included from eight practices: one academic hospital, five general hospitals, and ...
Autoantibodies to two novel peptides in seronegative and early rheumatoid arthritis Universiteit Hasselt
Psychosocial burden predicts sustained remission in early rheumatoid arthritis Vrije Universiteit Brussel KU Leuven
Objective: This study investigated how psychosocial aspects of disease affect the probability of achieving sustained remission in early rheumatoid arthritis (RA) and explored the directionality of this relationship. Methods: Data were analyzed from the randomized controlled Care in Early RA trial. Sustained remission was defined as a continued Disease Activity Score in 28 joints using the C-reactive protein level (DAS28-CRP) of <2.6 from ...
Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment Vrije Universiteit Brussel KU Leuven Universiteit Hasselt
Objectives: To compare the efficacy and safety of intensive combination strategies with glucocorticoids (GCs) in the first 16 weeks (W) of early rheumatoid arthritis (eRA) treatment, focusing on high-risk patients, in the Care in early RA trial. Methods: 400 disease-modifying antirheumatic drugs (DMARD)-naive patients with eRA were recruited and stratified into high risk or low risk according to classical prognostic markers. High-risk ...